Free tool
Heavily traded stocks
We cover 32 companies whose typical session turns over more than $10.00M. The median market value in the group is $1.44B. Across the group, the median move over the past trading day is −0.06%. 100% of the 32 with a 200-day average trade above it. Price change over the past year runs from −32.5% to +446.6% across the middle 80 percent of the group, with a median of +81.8%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
32 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| V | Visa Inc. | $716.76B | Mega cap | +10.25% |
| MA | Mastercard Incorporated | $525.05B | Mega cap | +1.78% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| ASST | Strive, Inc. | $1.93B | Small cap | −81.81% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| SBET | Sharplink, Inc. | $1.81B | Small cap | −56.82% |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% |
| CXM | Sprinklr, Inc. | $1.75B | Small cap | −13.74% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| SAFT | Safety Insurance Group, Inc. | $1.52B | Small cap | +46.60% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% |
| UTZ | Utz Brands, Inc. | $1.26B | Small cap | +7.46% |
| GO | Grocery Outlet Holding Corp. | $1.21B | Small cap | −34.00% |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% |
| HZO | MarineMax, Inc. | $1.15B | Small cap | +86.51% |
| IMMX | Immix Biopharma, Inc. | $1.00B | Small cap | +617.86% |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% |
| MNTN | MNTN, Inc. | $988.90M | Small cap | −37.80% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| MLAB | Mesa Laboratories, Inc. | $712.63M | Small cap | +85.96% |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| REAX | The Real Brokerage Inc. | $579.51M | Small cap | +414.31% |
| BYND | Beyond Meat, Inc. | $245.01M | Small cap | +450.19% |
| PMI | Picard Medical, Inc. | $20.13M | Micro cap | +113.51% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.